ASCAR
Newgenivf Group Limited
A special purpose acquisition company—a "blank check" shell that raises money in an initial public offering, then hunts for a private company to merge with and take public. Founded in 2022 and incorporated in the British Virgin Islands, it set its sights on fast-growing technology, media, and telecom firms in the US and Asia, and in 2024 it merged with NewGenIvf, a fertility services provider. The name is a wink at the whole idea: "A SPAC I" spells out a pun on "spacy" and marks it as the first in a series of sponsor vehicles.
RIGHTUnderlying: ASCARCINS: G0542S114HealthcareTH1 holder
Rights of A SPAC I Acquisition Corp, expired following the April 3, 2024 business combination with NewGenIvf Group Limited — Delisted; rights ceased trading after business combination closed April 3, 2024
Total Value
$18.0K
Total Shares
145.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
